$64.97
0.08% today
Nasdaq, Feb 28, 05:23 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Stock price

$65.02
-9.67 12.95% 1M
-16.44 20.18% 6M
-15.50 19.25% YTD
+14.27 28.12% 1Y
+40.04 160.29% 3Y
+23.08 55.03% 5Y
+23.08 55.03% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-3.09 4.54%
ISIN
US74276L1052
Symbol
PRCT
Sector

Key metrics

Market capitalization $3.54b
Enterprise Value $3.28b
P/E (TTM) P/E ratio negative
EV/Sales (TTM) EV/Sales 14.62
P/S ratio (TTM) P/S ratio 15.75
P/B ratio (TTM) P/B ratio 14.06
Revenue growth (TTM) Revenue growth 64.84%
Revenue (TTM) Revenue $224.50m
EBIT (operating result TTM) EBIT $-96.61m
Cash position $333.73m
EPS (TTM) EPS $-1.76
P/E forward negative
P/S forward 10.99
EV/Sales forward 10.20
Short interest 14.21%
Show more

Is PROCEPT BioRobotics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

PROCEPT BioRobotics Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a PROCEPT BioRobotics forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a PROCEPT BioRobotics forecast:

Buy
82%
Hold
18%

Financial data from PROCEPT BioRobotics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
225 225
65% 65%
100%
- Direct Costs 91 91
32% 32%
41%
133 133
99% 99%
59%
- Selling and Administrative Expenses 166 166
30% 30%
74%
- Research and Development Expense 59 59
32% 32%
26%
-91 -91
13% 13%
-41%
- Depreciation and Amortization 5.23 5.23
27% 27%
2%
EBIT (Operating Income) EBIT -97 -97
11% 11%
-43%
Net Profit -91 -91
14% 14%
-41%

In millions USD.

Don't miss a Thing! We will send you all news about PROCEPT BioRobotics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PROCEPT BioRobotics Stock News

Neutral
GlobeNewsWire
3 days ago
SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the fourth quarter and year ended December 31, 2024.
Neutral
GlobeNewsWire
21 days ago
SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2024 after market close on Tuesday, February 25, 2025. The Company's management will host a corresponding...
Neutral
Business Wire
about one month ago
NEW YORK--(BUSINESS WIRE)--Spruce Point Capital Management, LLC (“Spruce Point” or “we” or “us”), a New York-based investment management firm that focuses on forensic research and short-selling, today issued a detailed report entitled, “Pulling Back the Curtain on Procept,” that outlines why we believe and estimate that shares of PROCEPT BioRobotics (Nasdaq: PRCT) (“Procept” or the “Company”) f...
More PROCEPT BioRobotics News

Company Profile

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.

Head office United States
CEO Reza Zadno
Founded 2007
Website www.procept-biorobotics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today